Growth through acquisitions Vimian has a track record of expanding via strategic acquisitions (iM3 Dental, AllAccem, Avacta Animal Health, NGD assets, Heiland GmbH), indicating a potential need for integration, ERP optimization, cross-selling of products and services, and scalable tech and supply chain solutions to support rapid onboarding of acquired businesses.

Global veterinary reach With presence in over 80 markets and more than 17,000 clinics and labs reached, there is a clear opportunity to offer centralized solutions that streamline multi-market operations, including regional compliance, distribution, and support platforms, as well as multilingual marketing and training programs.

Diverse product portfolio Operating across Specialty Pharma, MedTech, Veterinary Services, and Diagnostics suggests cross-sell opportunities for bundled solutions, maintenance contracts, sterilization and workflow optimization tools, plus data-driven diagnostics and telemedicine capabilities to enhance clinic profitability.

Digital infrastructure Current tech stack includes SAP, NetSuite, QuickBooks, Tableau, and iCIMS, signaling a maturity in enterprise software use; this presents opportunities to upsell advanced analytics, CRM enhancements, supply chain optimization, and integration projects leveraging existing platforms.

Executive leadership change Appointment of a new CEO in late 2025 may drive strategic pivots and growth initiatives; sales teams can align with leadership priorities by presenting scalable solutions for accelerated expansion, integration post-acquisitions, and international market penetration.